The pathophysiologie and treatment of graft-versus-host diseaseSULLIVAN, K. M; PARKMAN, R.Clinics in haematology. 1983, Vol 12, Num 3, pp 775-789, issn 0308-2261Article

The ability of murine cytomegalovirus and class I major histocompatability complex-disparate parental cells to induce alterations characteristic of severe graft-versus-host reactionsCRAY, C; LEVY, R. B.Transplantation. 1989, Vol 48, Num 6, pp 1057-1063, issn 0041-1337, 7 p.Article

Graft-vs-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigensSHEARER, G. M; LEVY, R. B.The Journal of experimental medicine. 1983, Vol 157, Num 3, pp 936-946, issn 0022-1007Article

Graft-versus-host disease in a patient with acute lymphoblastic lymphomaMUTASIM, D. F; BADR, K; SAAB, G et al.Cutis (New York, NY). 1984, Vol 33, Num 2, pp 206-210, issn 0011-4162Article

Immunologic, clinical, and pathologic aspects of human graft-versus-host diseaseWICK, M. R; MOORE, S. B; GASTINEAU, D. A et al.Mayo Clinic proceedings. 1983, Vol 58, Num 9, pp 603-612, issn 0025-6196Article

Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 miceBRYSON, J. S; JENNINGS, C. D; CAYWOOD, B. E et al.Transplantation. 1989, Vol 48, Num 6, pp 1042-1047, issn 0041-1337, 6 p.Article

Prévention de la maladie du greffon contre l'hôte: élimination des lymphocytes T des cellules médullaires par cytolyse complément dépendante avec une combinaison d'anticorps monocionaux pan-T = Use of anti T cell monoclonal antibody to eliminate T lymphocytes and prevent graft versus host diseaseHERVE, P; RACADOT, E; FLESCH, M et al.La Presse médicale (1983). 1984, Vol 13, Num 14, pp 886-887, issn 0755-4982Article

Graft-versus-host diseaseGALE, R. P.Immunological reviews. 1985, Num 88, pp 193-214, issn 0105-2896Article

Graft-versus-host disease from leukocyte transfusionsTOLBERT, B; KAUFMAN, C. E. JR; BURGDORF, W. H. C et al.Journal of the American Academy of Dermatology. 1983, Vol 9, Num 3, pp 416-419, issn 0190-9622Article

Scleroderma-like changes due to chronic graft-versus-host diseaseGRAHAM-BROWN, R. A. C; SARKANY, I.Clinical and experimental dermatology (Print). 1983, Vol 8, Num 5, pp 531-538, issn 0307-6938Article

Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood productsLABOTKA, R. J; RADVANY, R.Medical and pediatric oncology. 1985, Vol 13, Num 2, pp 101-104, issn 0098-1532Article

Variation in blood component irradiation practice : implications for prevention of transfusion-associated graft-versus-host diseaseANDERSON, K. C; GOODNOUGH, L. T; SAYERS, M et al.Blood. 1991, Vol 77, Num 10, pp 2096-2102, issn 0006-4971Article

Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host diseaseSPISEK, Radek; GASOVA, Zdena; BARTUNKOVA, Jirina et al.Transfusion (Philadelphia, PA). 2006, Vol 46, Num 1, pp 55-65, issn 0041-1132, 11 p.Article

Antilymphocytic antibodies and marrow transplantation. XIV, Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathwaysTHIERFELDER, S; MYSLIWIETZ, J; HOFFMANN-FEZER, G et al.Blood. 1991, Vol 77, Num 10, pp 2285-2291, issn 0006-4971Article

Graft-versus-host reaction in 3 adult leukaemia patients after transfusion of blood cell productsNIKOSKELAINEN, J; SÖDERSTRÖM, K.-O; RAJAMÄKI, A et al.Scandinavian journal of haematology. 1983, Vol 31, Num 5, pp 403-409, issn 0036-553XArticle

Transfusion-associated graft-versus-host disease in immunocompetent patients : case series and review of the literatureAGBAHT, Kemal; ALTINTAS, Neriman Defne; TOPELI, Arzu et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 8, pp 1405-1411, issn 0041-1132, 7 p.Article

Prévention et traitement de la réaction aiguë du greffon contre l'hôteHERVE, P.La Presse médicale (1983). 1991, Vol 20, Num 33, pp 1614-1621, issn 0755-4982Article

La maladie du greffon contre l'hôte après transfusion = Graft-versus host disease after transfusionCHAPUIS, B.Médecine et hygiène. 1984, Vol 42, Num 1585, pp 3626-3632, issn 0025-6749, 3 p.Article

Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantationKAMINSKI, E; HOWS, J; MAN, S et al.Transplantation. 1989, Vol 48, Num 4, pp 608-613, issn 0041-1337, 6 p.Article

Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in manJANIN-MERCIER, A; DEVERGIE, A; VAN CAUWENBERGE, D et al.The American journal of pathology. 1984, Vol 115, Num 2, pp 296-306, issn 0002-9440Article

La réaction du greffon contre l'hôte = Graft vs host diseaseMOALIC, V; FEREC, C.Pathologie et biologie. 2006, Vol 54, Num 5, pp 304-308, issn 0369-8114, 5 p.Article

Is there an effective therapy for chronic graft-versus-host disease ?SCHILLER, G; GALE, R. P.Bone marrow transplantation (Basingstoke). 1993, Vol 11, Num 3, pp 189-192, issn 0268-3369Article

Post-transfusional syndrome like graft versus host diseaseHISATOMI, K; HIRANO, K; OKUDA, K et al.Nippon Geka Gakkai Zasshi. 1993, Vol 94, Num 4, pp 334-340, issn 0301-4894Article

Thalidomide for the treatment of chronic graft-versus-host diseaseVOGELSANG, G. B; FARMER, E. R; SANTOS, G. W et al.The New England journal of medicine. 1992, Vol 326, Num 16, pp 1055-1058, issn 0028-4793Article

What determines who develops graft-versus-host disease : the graft or the host (or both) ?GALE, R. P; HOROWITZ, M. M; BUTTURINI, A et al.Bone marrow transplantation (Basingstoke). 1992, Vol 10, Num 2, pp 99-102, issn 0268-3369Article